Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Innate Pharma SA announces its turnover for the third quarter of 2009 and updates on its cash situation
November 6, 2009
- Turnover for the first nine months of 2009 amounted to 2.8 million euros
- As at September 30, 2009, cash, cash equivalents and current financial instruments amounted 30.5 million euros
| Download Area |
|---|
| PR in english |
| CP en français |